Mohsin Ali, MD
Retina Specialist · Greenbelt, MDNPI 1063855534
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by AbbVie at 54.4% of the total.
Across 117 payments — averaging $118.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Alimera Sciences, Inc.$2K
- Dutch Ophthalmic, USA$928
- Genentech USA, Inc.$581
- Apellis Pharmaceuticals, Inc.$298
- Astellas Pharma US Inc$256
- plus $2K from 16 others
Across 43 payments — averaging $32.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$1K
What the payments were for
- Consulting fees$5,70041%
- Travel & lodging$3,85728%
- Food & beverage$4,33031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $7,561 |
| Alimera Sciences, Inc. | 8 | $2,190 |
| Dutch Ophthalmic, USA | 2 | $928 |
| Genentech USA, Inc. | 21 | $581 |
| Apellis Pharmaceuticals, Inc. | 7 | $298 |
| Astellas Pharma US Inc | 9 | $256 |
| Alcon | 2 | $235 |
| Regeneron Healthcare Solutions, Inc. | 7 | $225 |
| Eyepoint US, Inc. | 7 | $181 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $171 |
| ANI Pharmaceuticals, Inc. | 3 | $169 |
| Rxsight Inc | 2 | $151 |
| Coopervision Inc. | 1 | $143 |
| Bausch & Lomb Americas Inc. | 7 | $140 |
| Biotissue Holdings Inc. | 1 | $137 |
| Tarsus Pharmaceuticals, Inc. | 1 | $136 |
| Dompe US, Inc. | 1 | $125 |
| Genentech, Inc. | 2 | $81 |
| Sandoz | 2 | $57 |
| Novartis | 3 | $55 |
| Coherus Oncology, Inc. | 2 | $47 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OZURDEX$6,975
- Iluvien$2,090
- EVA, combined machine$840
- TISSUEBLUE$840
- MiSight Contact Lens$143
- Prokera$137
- XDEMVY$136
- Oxervate$125
- ReSTOR$120
- TRYPTYR$115
- STELLARIS PC$115
- Syfovre$113
- PURIFIED CORTROPHIN GEL$112
- OCREVUS$108
How this compares
$13,887 in reported general payments places this provider in the 85th percentile of 47 retina specialist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 58 | $2,982 |
| Ketorolac Tromethamine | 44 | $872 |
| Ofloxacin | 24 | $453 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 19 | $397 |
| Brimonidine Tartrate | 11 | $381 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 24 | $262 |
| ErythromycinErythromycin Base | 20 | $203 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Greenbelt
- Reginald SandersGreenbelt$24K
- Mariam MathaiGreenbelt$4K
- Sneha PadidamGreenbelt$4K
- Joshua LevinsonGreenbelt$4K
- Jason HuangGreenbelt$3K
- Collin OhningGreenbelt$1K
- Geoffrey KaplanGreenbelt$792
- Rohit LakhanpalOwings Mills$168K
- Brian DoChevy Chase$116K
- Adam GerstenblithHagerstown$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.